AmSurg (AMSG) Reports In-Line Q3 EPS, FY Rev. Guidance Tops Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
AMSURG Reports Third-Quarter Diluted EPS of $0.69 and Adjusted Diluted EPS of $1.13
November 1, 2016 4:06 PM EDTAdjusts 2016 Financial Guidance
NASHVILLE, Tenn.--(BUSINESS WIRE)-- AMSURG Corp. (NASDAQ: AMSG) today announced financial results for the third quarter and nine months ended September 30, 2016. The Companys results for the quarter, compared with the third quarter of 2015, included:
Net revenues of $822.2 million, up 26% from $650.2 million for the third quarter of 2015; Net earnings attributable to AMSURG common shareholders of $37.7 million, a decline of 7%, and $0.69 per diluted share, a decline of 17%, primarily due to transaction costs related to AMSURGs proposed merger with Envision Healthcare and to AMSURGs... More